MiR‐21 is also upregulated in HCV‐associated HCC, targeting and inhibiting SMAD7 in the transforming growth factor beta (TGF‐β) signaling pathway, promoting liver fibrosis and tumorigenesis [257]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.